Locations:
SearchAdvertisement
Findings establish overweight/obesity as a modifiable risk factor for cardiovascular disease
Undetectable levels achieved for nearly nine months in phase 1 trial
Study sheds light on how clinicians addressed their patients’ pain and insomnia during the pandemic
For now, antibody testing is recommended only when considering an alternative diagnosis
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Observational study supports adding CAC score to traditional risk factors for precision medicine approach
Results inform dose selection for further trials of the aldosterone synthase inhibitor
A review of takeaways from the recent U.K. national guidelines
Integrate climate-related health information and counseling into your practice
Robust reductions in cardiac events seen in high-risk patients without prior events
But findings apply only to middle-aged or older men with confirmed hypogonadism
Advertisement
Advertisement